Niki BioSolutions, Inc. — Form 8-K
Filed July 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 27/100
What the filing says
On July 20, 2026, Aptorum Group Limited (NASDAQ: APM) completed its all-stock merger with DiamiR Biosciences Corp., reincorporating as Niki BioSolutions, Inc. (NASDAQ: NIKI). The company executed a 1-for-10 reverse stock split (reducing ~8.1M Aptorum shares to ~814K post-split), issued 1,810,000 Series A Preferred Shares (stated value $0.0001, liquidation preference equal to stated value plus 70% of net proceeds from asset sales of Alzheon Common Stock), and established governance with a 5-member board including 2 designees for DiamiR founder Kira Sheinerman (primary stockholder) while she owns ≥36% of outstanding shares.
Why this rating
Merger closes merger announced 1 year prior; routine post-close governance docs. Size ~$18.7M; no material M&A or financing disclosed. Administrative event.
See more from July 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.